2026-2034年全球醫療保健產業區塊鏈技術市場規模、佔有率、趨勢和成長分析報告

預計醫療領域區塊鏈技術的市場規模將從 2025 年的 199.7 億美元成長到 2034 年的 1,6959.3 億美元，2026 年至 2034 年的複合年成長率為 63.81%。

由於對資料安全和互通性的日益關注，全球醫療保健領域的區塊鏈技術市場正在快速擴張。醫療機構擴大採用區塊鏈解決方案，以實現安全的病患資料交換、供應鏈透明化和防範詐欺。醫療記錄的數位化和網路威脅的增加正在加速醫院和研究機構對區塊鏈技術的應用。

關鍵成長要素包括對更透明的臨床試驗管理、安全的藥品供應鏈和改進的患者知情同意系統的需求。區塊鏈提供的防篡改記錄增強了醫療保健生態系統內的信任和合規性。對數位醫療基礎設施的投入增加以及科技公司與醫療服務提供者之間的合作，進一步推動了市場成長。

展望未來，與現有醫療IT系統的廣泛整合以及監管支持將是推動市場加速發展的關鍵因素。去中心化身分系統的採用和人工智慧區塊鏈平台的引入有望提升擴充性。儘管實施成本和整合挑戰依然存在，但具有可衡量投資報酬率的重點應用案例有望推動長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫療保健產業區塊鏈技術市場：按網路類型分類

• 市場分析、洞察與預測
• 私人的
• 民眾
• 其他

第5章：全球醫療保健產業區塊鏈技術市場：按應用領域分類

• 市場分析、洞察與預測
• 臨床數據交換和互通性
• 索賠審核和計費操作
• 供應鏈管理
• 臨床試驗及電子知情同意書
• 其他

第6章：全球醫療保健產業區塊鏈技術市場：依最終用途分類

• 市場分析、洞察與預測
• 提供者
• 付款人
• 生物製藥和醫療設備製造商
• 其他

第7章：全球醫療保健產業區塊鏈技術市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 亞太其他地區
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • IBM Corporation
  • Patientory Inc
  • Guardtime
  • ISolve LLC
  • Solve.Care
  • Oracle Corporation
  • Change Healthcare
  • BurstIQ
  • Medicalchain SA
  • Blockpharma
  • Digital Diagnostics Inc

The Blockchain Technology in Healthcare Market size is expected to reach USD 1695.93 Billion in 2034 from USD 19.97 Billion (2025) growing at a CAGR of 63.81% during 2026-2034.

The Global Blockchain Technology in Healthcare Market is witnessing rapid expansion due to growing concerns regarding data security and interoperability. Healthcare organizations are exploring blockchain solutions for secure patient data exchange, supply chain transparency, and fraud prevention. Increasing digitization of health records and rising cyber threats are accelerating adoption across hospitals and research institutions.

Major growth drivers include the need for transparent clinical trial management, secure pharmaceutical supply chains, and improved patient consent systems. Blockchain's ability to provide immutable records enhances trust and compliance within healthcare ecosystems. Rising investments in digital health infrastructure and collaborations between technology firms and healthcare providers further stimulate market growth.

Looking forward, broader integration with existing health IT systems and regulatory support will determine market acceleration. Adoption of decentralized identity systems and AI-powered blockchain platforms may enhance scalability. While implementation costs and integration challenges remain, focused use cases with measurable ROI are expected to drive long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Network Type

• Private
• Public
• Others

By Application

• Clinical Data Exchange & Interoperability
• Claims Adjudication & Billing
• Supply Chain Management
• Clinical Trials & eConsent
• Others

By End-use

• Providers
• Payers
• Biopharmaceutical & Medical Device Companies
• Others

COMPANIES PROFILED

• IBM Corporation, Patientory Inc, Guardtime, iSolve LLC, SolveCare, Oracle Corporation, Change Healthcare, BurstIQ, Medicalchain SA, Blockpharma, Digital Diagnostics Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET: BY NETWORK TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Network Type
• 4.2. Private Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Data Exchange & Interoperability Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Claims Adjudication & Billing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Supply Chain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Clinical Trials & eConsent Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Biopharmaceutical & Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Network Type
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Network Type
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Network Type
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Network Type
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Network Type
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BLOCKCHAIN TECHNOLOGY IN HEALTHCARE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 IBM Corporation
  • 9.2.2 Patientory Inc
  • 9.2.3 Guardtime
  • 9.2.4 ISolve LLC
  • 9.2.5 Solve.Care
  • 9.2.6 Oracle Corporation
  • 9.2.7 Change Healthcare
  • 9.2.8 BurstIQ
  • 9.2.9 Medicalchain SA
  • 9.2.10 Blockpharma
  • 9.2.11 Digital Diagnostics Inc